Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
NYSE:KVUE
Kenvue, Inc. (KVUE) Stock Price & Analysis
598 Followers
KVUE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.27 - $24.25
Previous Close$18.25
Volume15.41M
Average Volume (3M)22.59M
Market Cap
$34.95B
Enterprise Value$42.35B
Total Cash (Recent Filing)$1.16B
Total Debt (Recent Filing)$8.55B
Price to Earnings (P/E)23.5
Beta0.75
Next Earnings
Aug 06, 2024EPS Estimate
$0.28Last Dividend Ex-Date
May 07, 2024Dividend Yield4.38%
Share Statistics
EPS (TTM)0.78
Shares Outstanding1,914,810,796
10 Day Avg. Volume23,501,774
30 Day Avg. Volume22,589,556
Standard Deviation0.09
R-Squared0.50
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-4.56
Price to Sales (P/S)9.68
Price to Cash Flow (P/CF)30.90
P/FCF Ratio44.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.73
Enterprise Value/Gross Profit4.90
Enterprise Value/Ebitda19.72
Forecast
1Y Price Target
$21.13Price Target Upside15.78% Upside
Rating ConsensusHold
Number of Analyst Covering9
Kenvue, Inc. News
Bulls Say, Bears Say
Bulls Say
Advertising SpendStepped-up advertising spend from 8-9% as a percentage of sales, to closer to ~10% after this year and ultimately approaching peers at 11%-12%.
Cost Savings And ReinvestmentKVUE’s Our Vue Forward, which is expected to generate savings of $350mn, a portion of which will be reinvested.
Investments And StrategyManagement’s increased investments and other internal cultural shifts as they strengthen their approach/strategy as a standalone company, ultimately becoming more agile.
Bears Say
Earnings PerformanceWorse-than-expected performance in Skin Health & Beauty in the U.S. as the Neutrogena brand continues to struggle to recover shelf space and market share.
Market ShareOngoing challenges in the U.S. as Neutrogena struggles to recover share, creating a negative outlook for the stock.
VisibilityKVUE valuation is expected to stay depressed vs. peers until investors have more visibility on the near/medium-term picture.
---
Ownership Overview
9.54% Insiders
35.84% Mutual Funds
23.72% Other Institutional Investors
30.90% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $17.27 and its highest was $24.25 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Currently, no data Available
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Aug 06, 2024 which is in 16 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on May 07, 2024. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.254 by $0.026.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Semiannually dividend of $0.2 which represents an annual dividend yield of 4.38%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is $0.28.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,914,814,700 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.254. Following the earnings report the stock price went up 6.356%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Among the largest hedge funds holding Kenvue, Inc.’s share is Gates Capital Management, Inc.. It holds Kenvue, Inc.’s shares valued at 152M.
---
Kenvue, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$21.13 (15.78% Upside)
$21.13 (15.78% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 95%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 534.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.04%
12-Months-Change
Fundamentals
Return on Equity
9.65%
Trailing 12-Months
Asset Growth
-23.35%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue Inc is a pure-play consumer health company. It is a global leader at the intersection of healthcare and consumer goods, with a portfolio of iconic brands, operating in some of the most attractive categories in consumer health. The consumer health portfolio includes self-care, skincare and beauty and essential personal care products.
---
KVUE Company Deck
---
KVUE Earnings Call
Q1 2024
0:00 / 0:00
---
KVUE Revenue Breakdown
41.77% Self Care
29.88% Essential Health
28.35% Skin Health and Beauty
---
KVUE Stock 12 Month Forecast
Average Price Target
$21.13
▲(15.78% Upside)
Technical Analysis
Best Analysts Covering KVUE
1 Year
1 Year Success Rate
1/10 ratings generated profit
1 Year Average Return
-10.69%
reiterated a buy rating 12 days ago
Copying Anna Lizzul's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -10.69% per trade.
---